PYC Therapeutics Limited (AU:PYC) has released an update.
PYC Therapeutics Limited has reported a change in substantial holding by David Sietsma, with his voting power in the company decreasing from 7.60% to 6.07%. This shift reflects a dilution of Sietsma’s original holdings due to an increase in the number of outstanding shares. These changes have been formally documented in accordance with the requirements of the Corporations Act 2001.
For further insights into AU:PYC stock, check out TipRanks’ Stock Analysis page.
